Displaying archives for 2014 March:

Key Protein Identified That Helps Prevent Lung Cancer Tumors From Being Destroyed

Posted by Samantha Powell on March 26th, 2014 |

Date: 3/26/14 Outlet Full Name: Oncology Nurse Advisor Author: Kathy Boltz http://www.oncologynurseadvisor.com/key-protein-identified-that-helps-prevent-lung-cancer-tumors-from-being-destroyed/article/340009/ Eliminating the protein Mcl-1 could make radiation and chemotherapies more effective in treating the most common and deadly of all cancers, non-small cell lung cancer (NSCLC). Mcl-1 helps to enable NSCLC to survive radiation and drug treatments. NSCLC makes up about 85% of… Read More

Kellen Reid Plays Every Game For His Late Mother, But Aims to Carry Her Legacy Beyond the Pitch

Posted by Samantha Powell on March 25th, 2014 |

Date: 3/25/14 Outlet Full Name: Dallas Morning News Author: Matt Wixon http://www.dallasnews.com/sports/high-schools/matt-wixon/20140325-kellen-reid-plays-every-game-for-his-late-mother-but-aims-to-carry-her-legacy-beyond-the-soccer-pitch.ece For the last two seasons, Kellen Reid has wiped away scoring chances for opponents of Coppell’s powerhouse soccer team. The defender has marked shifty attackers, cleared dangerous crossing passes and organized the back line of the Cowboys’ stingy defense. “He’s been the anchor,”… Read More

Ariad Begins Trial of Lung Cancer Drug, Says Side Effects Will Be Different From Iclusig

Posted by Samantha Powell on March 24th, 2014 |

Date: 3/24/14 Outlet Full Name: Boston Business Journal Author: Don Seiffert http://www.bizjournals.com/boston/blog/bioflash/2014/03/ariad-begins-trial-of-lung-cancer-drug-says-side.html?page=all Ariad Pharmaceuticals has begun a trial to study a treatment for the most common form of lung cancer, and while the drug works the same way as the biotech firm’s first approved drug, Iclusig, the company doesn’t expect it to show similar side… Read More

When it comes to lung cancer… ‘Catch it to cure it’

Posted by Samantha Powell on March 24th, 2014 |

Date: 3/24/14 Outlet Full Name: The Daily Times Author: Jennie Bounds http://www.thedailytimes.com/community/when-it-comes-to-lung-cancer-catch-it-to-cure/article_8c7f8461-6c61-5bd0-8a8f-230c9b54d6ab.html “Catch it to cure it.” Those are the words of Blount Memorial Hospital thoracic surgeon Dr. Jason Budde when it comes to discussions about lung cancer. “To have the best chance for a cure from cancer, you have to catch it before it’s… Read More

ASCO: ‘Smaller, smarter’ cancer trials will yield more meaningful results

Posted by Samantha Powell on March 24th, 2014 |

Date: 3/24/14 Outlet Full Name: Healio Hematology/Oncology Author: Ellis LM http://www.healio.com/hematology-oncology/practice-management/news/online/%7Bdbf305e6-0b11-48aa-a214-f47c9874b716%7D/asco-smaller-smarter-cancer-trials-will-yield-more-meaningful-results ASCO recently released new recommendations designed to increase the likelihood of “clinical meaningful outcomes” in trials for advanced pancreatic, lung, breast and colon cancers. The recommendations — developed by the ASCO Cancer Research Committee in conjunction with other experts and patient advocates, and published… Read More

Lung Cancer: Germline Mutation Predisposes Women Who Never Smoked

Posted by Samantha Powell on March 24th, 2014 |

Date: 3/24/14 Outlet Full Name: Medical Research Author: N/A http://medicalresearch.com/cancer-_-oncology/lung-cancer/lung-cancer-germline-mutation-predisposes-women-never-smoked/4362/ Dr. Gazdar: We describe the characteristics of lung cancers arising in subjects who inherited a germline mutation that predisposes to lung cancer. The mutation is rare in the general populations, and is inherited equally by both sexes. However it is a potent predisposing gene, and… Read More

Runners take ‘Next Step’ to cure lung cancer

Posted by Samantha Powell on March 24th, 2014 |

Date: 3/24/14 Outlet Full Name: The Columbus Dispatch Author: N/A http://www.dispatch.com/content/stories/local/2014/03/24/runners-take-next-step-to-cure-lung-cancer.html Running helped keep participants warm during yesterday’s Your Next Step is the Cure event at Fred Beekman Park on Ohio State University’s West Campus. The 5-kilometer course welcomed both runners and walkers on a chilly early spring afternoon. The charity event raised money for… Read More

Memorial Cancer Institute Partners with Addario Foundation to Improve Standard of Care for Lung Cancer Patients

Posted by Samantha Powell on March 24th, 2014 |

Date: 3/24/14 Outlet Full Name: Businesswire Author: Matt Notley and Kerting Baldwin http://www.businesswire.com/news/home/20140324005239/en/Memorial-Cancer-Institute-Partners-Addario-Foundation-Improve#.UzBjvqhdXDU The Bonnie J. Addario Lung Cancer Foundation (ALCF) announced today the addition of Memorial Cancer Institute (MCI) in Hollywood, Florida, a part of Memorial Healthcare Systems, to its 360 Community Hospital Centers of Excellence Program, which aims to improve individualized standard of… Read More

Characteristics of Lung Cancer Arising in Germline EGFR T790M Mutation Carriers

Posted by Samantha Powell on March 21st, 2014 |

Date: 3/21/14 Outlet Full Name: Medical Xpress Author: No author http://medicalxpress.com/news/2014-03-characteristics-lung-cancers-germline-egfr.html Two studies are providing new insight into germline epidermal growth factor receptor (EGFR) T790M mutation in familial non-small cell lung cancer (NSCLC). The findings suggest the need for tailored approaches for early detection and treatment, as well as for genetic testing to identify carriers…. Read More

National cancer network receives $2M in research funding

Posted by Samantha Powell on March 21st, 2014 |

Date: 3/21/14 Outlet Full Name: San Diego Daily Transcript Author: N/A http://www.sddt.com/News/article.cfm?SourceCode=20140321tqc#.UzBlWahdXDU The National Comprehensive Cancer Network (NCCN) Oncology Research Program (ORP) has been awarded a $2 million grant from Boehringer Ingelheim Pharmaceuticals Inc. to develop a program to scientifically evaluate and define the safety and clinical effectiveness of the investigational compound nintedanib (BIBF 1120)… Read More